Quercetin protects against obesity-induced skeletal muscle inflammation and atrophy

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Le, Ngoc Hoan ^a   Kim, Chu Sook ^a   Park, Taesun ^b   Park, Jung Han Yoon ^c   Sung, Mi Kyung ^d   Lee, Dong Gun ^e   Hong, Sun Myung ^a   Choe, Suck Young ^a   Goto, Tsuyoshi ^f   Kawada, Teruo ^f   Yu, Rina ^a  

^a University of Ulsan   (South Korea)

^b Yonsei University   (South Korea)

^c Hallym University   (South Korea)

^d Sookmyung Women's University   (South Korea)

^e Kyungpook National University   (South Korea)

^f KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; CD68 ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; MUSCLE RING FINGER 1 PROTEIN; PALMITIC ACID; QUERCETIN; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; CYTOKINE; FBXO32 PROTEIN, MOUSE; MUSCLE PROTEIN; TRIM63 PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME DEGRADATION; GASTROCNEMIUS MUSCLE; IN VITRO STUDY; LIPID DIET; MACROPHAGE; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE MASS; MYOSITIS; MYOTUBE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE INFLAMMATION; SOLEUS MUSCLE; WESTERN BLOTTING; ANIMAL; ATROPHY; C57BL MOUSE; CELL LINE; CHEMISTRY; COMPLICATION; INFLAMMATION; INSULIN RESISTANCE; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SARCOPENIA; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

MUS;

ANIMALS; ANTIOXIDANTS; ATROPHY; BASE SEQUENCE; CELL LINE; CYTOKINES; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MUSCLE PROTEINS; MUSCLE, SKELETAL; OBESITY; QUERCETIN; SARCOPENIA; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN-PROTEIN LIGASES;

EID: 84921300891     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/834294     Document Type: Article

References (40)

1. G. Biolo, T. Cederholm, andM. Muscaritoli, "Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia," Clinical Nutrition, vol. 33, no. 5, pp. 737-748, 2014.
2. W. J. Durham, E. L. Dillon, and M. Sheffield-Moore, "Inflammatory burden and amino acidmetabolism in cancer cachexia," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 12, no. 1, pp. 72-77, 2009.
3. A. L. Goldberg, "Probing the proteasome pathway," Nature Biotechnology, vol. 18, no. 5, pp. 494-496, 2000.
4. C. M. M. Prado, J. C. K. Wells, S. R. Smith, B. C. M. Stephan, and M. Siervo, "Sarcopenic obesity: a critical appraisal of the current evidence," Clinical Nutrition, vol. 31, no. 5, pp. 583-601, 2012.
5. C. N. Lumeng and A. R. Saltiel, "Inflammatory links between obesity and metabolic disease,"The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2111-2117, 2011.
6. A. Valerio, A. Cardile, V. Cozzi et al., "TNF- downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents," The Journal of Clinical Investigation, vol. 116, no. 10, pp. 2791-2798, 2006.
7. V. Varma,A. Yao-Borengasser,N. Rasouli et al., "Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action," American Journal of Physiology-Endocrinology and Metabolism, vol. 296, no. 6, pp. E1300-E1310, 2009.
8. P. Srikanthan, A. L. Hevener, and A. S. Karlamangla, "Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the national health and nutrition examination survey III," PLoS ONE, vol. 5, no. 5, Article ID e10805, 2010.
9. J. Terao, "Dietary flavonoids as antioxidants," Forum of Nutrition, vol. 61, pp. 87-94, 2009.
10. D. Kook, A. H. Wolf, A. L. Yu et al., "The protective effect of quercetin against oxidative stress in the human RPE in vitro," Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1712-1720, 2008.
11. A. Overman, C.-C. Chuang, and M. McIntosh, "Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage-conditioned media," International Journal of Obesity, vol. 35, no. 9, pp. 1165-1172, 2011.
12. M. Kobori, S. Masumoto, Y. Akimoto, and H. Oike, "Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice,"Molecular Nutrition and Food Research, vol. 55, no. 4, pp. 530-540, 2011.
13. H.-J. Noh, C.-S. Kim, J.-H. Kang et al., "Quercetin suppresses MIP-1-induced adipose inflammation by downregulating its receptors CCR1/CCR5 and inhibiting inflammatory signaling," Journal of Medicinal Food, vol. 17, no. 5, pp. 550-557, 2014.
14. C.-S. Kim and R. Yu, "The inhibitory effect of quercetin on adipose tissue inflammation in mice fed on a high-fat diet," The Korean Journal of Obesity, vol. 23, no. 3, pp. 170-178, 2014.
15. D. I. I. Hemdan, K. Hirasaka, R. Nakao et al., "Polyphenols prevent clinorotation-induced expression of atrogenes in mouse C2C12 skeletal myotubes," The Journal of Medical Investigation, vol. 56, no. 1-2, pp. 26-32, 2009.
16. R. Mukai, R. Nakao, H. Yamamoto, T. Nikawa, E. Takeda, and J. Terao, "Quercetin prevents unloading-derived disused muscle atrophy by attenuating the induction of ubiquitin ligases in tailsuspension mice," Journal of Natural Products, vol. 73,no. 10,pp. 1708-1710, 2010.
17. N. H. Le, C.-S. Kim, T. H. Tu et al., "Blockade of 4-1BB and 4-1BBL interaction reduces obesity-induced skeletal muscle inflammation," Mediators of Inflammation, vol. 2013,Article ID 865159, 10 pages, 2013.
18. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, "TLR4 links innate immunity and fatty acid-induced insulin resistance,"The Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015-3025, 2006.
19. B. Sishi, B. Loos, B. Ellis, W. Smith, E. F. du Toit, and A.-M. Engelbrecht, "Diet-induced obesity alters signalling pathways and induces atrophy and apoptosis in skeletal muscle in a prediabetic rat model," Experimental Physiology, vol. 96, no. 2, pp. 179-193, 2011.
20. D. Patsouris, P.-P. Li, D. Thapar, J. Chapman, J. M. Olefsky, and J. G. Neels, "Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals," Cell Metabolism, vol. 8, no. 4, pp. 301-309, 2008.
21. D. E. Kelley, B. Goodpaster, R. R. Wing, and J.-A. Simoneau, "Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss," The American Journal of Physiology-Endocrinology and Metabolism, vol. 277, no. 6, pp. E1130-E1141, 1999.
22. G. S. Hotamisligil, "Inflammation and metabolic disorders," Nature, vol. 444, no. 7121, pp. 860-867, 2006.
23. E. Atlantis, S. A. Martin, M. T. Haren, A. W. Taylor, and G. A. Wittert, "Inverse associations between muscle mass, strength, and the metabolic syndrome," Metabolism: Clinical and Experimental, vol. 58, no. 7, pp. 1013-1022, 2009.
24. T. M. Henagan, N. R. Lenard, T. W. Gettys, and L. K. Stewart, "Dietary quercetin supplementation in mice increases skeletal muscle PGC1 expression, improves mitochondrial function and attenuates insulin resistance in a time-specific manner," PLoS ONE, vol. 9, no. 2,Article ID e89365, 2014.
25. J. M. Davis, E. A. Murphy, M. D. Carmichael, and B. Davis, "Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance,"TheAmerican Journal of Physiology- Regulatory Integrative and Comparative Physiology, vol. 296, no. 4, pp. R1071-R1077, 2009.
26. L. K. Stewart, J. L. Soileau, D. Ribnicky et al., "Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet," Metabolism, vol. 57, supplement 1, pp. S39-S46, 2008.
27. G. F. Anhe, M. M. Okamoto, A. Kinote et al., "Quercetin decreases inflammatory response and increases insulin action in skeletalmuscle of ob/ob mice and in L6myotubes," European Journal of Pharmacology, vol. 689, no. 1-3, pp. 285-293, 2012.
28. L. Rivera, R. Morón,M. Sánchez, A. Zarzuelo, andM. Galisteo, "Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats," Obesity, vol. 16, no. 9, pp. 2081-2087, 2008.
29. S. C. Bodine, T. N. Stitt, M. Gonzalez et al., "Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo," Nature Cell Biology, vol. 3, no. 11, pp. 1014-1019, 2001.
30. S. C. Bodine, E. Latres, S. Baumhueter et al., "Identification of ubiquitin ligases required for skeletal muscle atrophy," Science, vol. 294, no. 5547, pp. 1704-1708, 2001.
31. S. E. Shoelson, J. Lee, and A. B. Goldfine, "Inflammation and insulin resistance," Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793-1801, 2006.
32. M. C. Samaan, "The macrophage at the intersection of immunity and metabolism in obesity," Diabetology and Metabolic Syndrome, vol. 3, no. 1, article 29, 2011.
33. D. Cai, J. D. Frantz,N. E. Tawa Jr. et al., "IKK/NF-B activation causes severe muscle wasting in mice," Cell, vol. 119, no. 2, pp. 285-298, 2004.
34. G. Zhang and Y.-P. Li, "P38 MAPK upregulates atrogin1/MAFbx by specific phosphorylation of C/EBP," Skeletal Muscle, vol. 2, no. 1, article 20, 2012.
35. F. Penna, D. Costamagna, A. Fanzani, G. Bonelli, F. M. Baccino, and P. Costelli, "Muscle wasting and impaired Myogenesis in tumor bearing mice are prevented by ERK inhibition," PLoS ONE, vol. 5, no. 10, Article IDe13604, 2010.
36. S. Huang, J. M. Rutkowsky, R. G. Snodgrass et al., "Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways," Journal of Lipid Research, vol. 53, no. 9, pp. 2002-2013, 2012.
37. A. Kennedy, K. Martinez, C.-C. Chuang, K. Lapoint, and M. Mcintosh, "Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications," The Journal of Nutrition, vol. 139, no. 1, pp. 1-4, 2009.
38. B. Kwon, "CD137-CD137 ligand interactions in inflammation," Immune Network, vol. 9, no. 3, pp. 84-89, 2009.
39. T. H. Tu, C.-S. Kim, T. Goto, T. Kawada, B.-S. Kim, and R. Yu, "4-1BB/4-1BBL interaction promotes obesity-induced adipose inflammation by triggering bidirectional inflammatory signaling in adipocytes/macrophages," Mediators of Inflammation, vol. 2012, Article ID 972629, 10 pages, 2012.
40. L. A. J. O'Neill, D. Golenbock, and A. G. Bowie, "The history of Toll-like receptors-redefining innateimmunity," Nature Reviews Immunology, vol. 13, no. 6, pp. 453-460, 2013.